Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Dual Therapeutics is focused on producing therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia.
- Matthew Galsky: Cofounder
Goutham Narla: Founder /MD & CSO
About the Company
Dual Therapeutics is focused on producing therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. Its small-molecule modulators are designed to simultaneously block multiple cancer-promoting pathways, especially those linked to growth and survival, thus allowing a more comprehensive assault on cancer cells without harming
healthy cells.
